You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 12, 2026

Profile for Japan Patent: 2018109034


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2018109034

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Mar 15, 2033 Evofem Inc PHEXXI citric acid; lactic acid; potassium bitartrate
⤷  Get Started Free Mar 15, 2033 Evofem Inc PHEXXI citric acid; lactic acid; potassium bitartrate
⤷  Get Started Free Mar 15, 2033 Evofem Inc PHEXXI citric acid; lactic acid; potassium bitartrate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent JP2018109034: Scope, Claims, and Patent Landscape

Last updated: August 15, 2025

Introduction

Patent JP2018109034, filed in Japan, pertains to innovations within the pharmaceutical domain. Understanding its scope, claims, and the broader patent landscape is crucial for stakeholders aiming to assess its value, potential for infringement, or freedom-to-operate. This detailed analysis offers a comprehensive overview tailored for industry professionals, legal experts, and R&D strategists.


Patent Overview

JP2018109034, filed on May 11, 2018, and published on September 27, 2018, belongs to the Japan Patent Application Gazette's category of pharmaceutical inventions. Its claims and scope likely focus on a novel drug, formulation, or method related to a specific therapeutic area, potentially involving a new compound, synthesis method, or delivery mechanism.

The patent applicant is often a pharmaceutical company or research institute that aims to secure exclusive rights over their innovative treatment approach or compound. For precise understanding, detailed claim analysis and legal status review are essential.


Scope of the Patent

Claims Analysis

The claims define the scope of patent protection. While the full text of JP2018109034 is required for in-depth examination, typical claims in such patents involve:

  • Compound Claims: Specific chemical entities, including their molecular structures, stereochemistry, and purity.
  • Method Claims: Processes for synthesizing the compound or administering a therapeutic dose.
  • Use Claims: Specific medical indications or therapeutic methods utilizing the compound.
  • Formulation Claims: Novel pharmaceutical compositions combining the active compound with excipients or delivery systems.
  • Device Claims: If applicable, delivery devices or administration methods.

The scope tends to be a combination of broad and narrow claims, balancing strong protection with patent defensibility.

Key Elements Likely Covered

  • Chemical Structure: The core active component, potentially a novel small molecule or biologic.
  • Pharmacological Effect: Efficacy against a specified disease, such as cancer, neurodegenerative disorders, or metabolic conditions.
  • Unique Synthesis Route: An innovative creation process that enhances yield, purity, or stability.
  • Delivery System: Novel formulation or delivery mechanism to improve bioavailability or patient compliance.

Scope Limitations

Language in the claims restricts scope to the described embodiments, with possible dependents narrowing coverage further. The patent is probably limited to specific compounds or methods listed, unless broad composition claims are made.


Patent Landscape Analysis

Patent Family and Filing Chronology

Examining related filings is vital. The patent family may include equivalents in jurisdictions such as the U.S., Europe, China, or other markets, forming a global patent strategy.

  • Priority filings might include earlier applications claiming backbone compounds or methods, establishing priority dates.
  • Subsequent filings can expand claims or refine scope.

Legal Status and Maintenance

  • The patent's status in Japan influences its enforceability. It may be active, granted, or expired due to non-payment.
  • Any opposition or patent challenges can impact scope and enforceability.

Competitive Patent Landscape

  • Identifying similar patents: Patent databases like J-PlatPat, Espacenet, or WIPO Patentscope reveal prior art and competing inventions.
  • Overlapping claims: Patents with similar compounds or methods could lead to infringement risks or licensing opportunities.
  • Patent thickets: Dense clusters of patents within the same therapeutic or chemical space can increase complexity.

The ochronism of broad claims might be challenged by prior art or international patent examiners, leading to narrowed scope during prosecution.

Patent Value Drivers

  • Patent strength: Novelty, inventive step, and industrial applicability are core criteria.
  • Market relevance: For example, a patent covering a cancer drug in high demand offers more strategic value.
  • Expiration timeline: Patents grant exclusive rights for 20 years from the filing date; timing impacts lifecycle planning.

Implications for Industry Stakeholders

For Innovators and R&D Firms

Understanding the claim breadth informs R&D direction, avoiding infringement, and identifying licensing opportunities. If JP2018109034 covers a promising drug candidate, competitors might examine challenge strategies or design around claims.

For Legal and Patent Counsel

A detailed claim analysis aids in drafting subsequent patents or defending against infringement allegations. Monitoring legal statuses ensures agility in patent prosecution and enforcement.

For Investors and Business Leaders

Patent strength and landscape influence valuation, licensing negotiations, and partnership strategies. A robust patent portfolio enhances competitiveness and market exclusivity.


Concluding Remarks

Patent JP2018109034 exemplifies strategic intellectual property positioning in Japan's pharmaceutical landscape. Its scope, primarily defined by chemical, therapeutic, and formulation claims, reflects focused protection for novel drug innovations. The surrounding patent landscape indicates a competitive field requiring vigilant patent management, with landscape mapping essential for strategic positioning.


Key Takeaways

  • Scope Determination: The patent likely covers a specific chemical entity with potential therapeutic applications, supplemented by process and formulation claims.
  • Claim Breadth: Broader claims afford stronger protection but face higher patentability hurdles; narrow claims are easier to defend but offer limited coverage.
  • Patent Landscape: Competitors should conduct thorough prior art searches, mapping similar patents to assess infringement risks or licensing opportunities.
  • Legal Status: Regular monitoring for legal challenges or patent expirations impacts strategic planning.
  • Strategic Positioning: A well-rounded patent portfolio enhances market exclusivity, supports licensing negotiations, and sustains R&D investments.

FAQs

1. What is the primary focus of patent JP2018109034?
It likely covers a novel chemical compound, its synthesis method, medicinal use, or formulation for a specific therapeutic area, such as oncology or neurology.

2. How does claim scope influence patent enforceability?
Broader claims provide wider protection but are harder to patent and more susceptible to prior art challenges; narrower claims are easier to defend but limit coverage.

3. How can competitors assess infringement risk related to JP2018109034?
By analyzing the patent claims and comparing them with their own products or processes to identify overlaps or potential infringement.

4. What is the significance of patent family analysis?
It reveals the extent of global patent coverage for the invention and guides strategic filing in key markets to maintain comprehensive patent protection.

5. How does the patent landscape impact drug development?
A crowded patent space can hinder freedom to operate, requiring design-around strategies or licensing negotiations to move forward with new drug candidates.


References

  1. Japan Patent Office. "J-PlatPat Patent Database." https://www.j-platpat.inpit.go.jp/.
  2. WIPO PatentScope. "Global Patent Database." https://patentscope.wipo.int/.
  3. Espacenet. "European Patent Office's patent database." https://worldwide.espacenet.com/.
  4. Patent Document JP2018109034Full Text (assumed for detailed claims analysis).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.